Combination of inulin-shellac as a unique coating formulation for design of colonic delivery dosage form of ibuprofen

Heni Rachmawati (1) , Diky Mudhakir (2) , Janti Kusuma (3)
(1) School of Pharmacy, Institute of Teknologi Bandung, Ganesha 10 Bandung 40132, Indonesia, Indonesia ,
(2) School of Pharmacy, Institute of Teknologi Bandung, Ganesha 10 Bandung 40132, Indonesia, Indonesia ,
(3) School of Pharmacy, Institute of Teknologi Bandung, Ganesha 10 Bandung 40132, Indonesia, Indonesia

Abstract

A combination of inulin and shellac, when applied as a film coat, has a potential value as a colon-specific delivery system for ibuprofen. The inulin-based multi-unit pellet system is prepared by coating inulin and shellac sequentially around drug-loaded cores in a fluid-bed coater. The outer shellac coating protects the system against gastrointestinal environment and dissolves rapidly in small intestine, where a lumen pH around 7 triggers the dissolution of the enteric polymer. The inner inulin coating works as a time-controlled retardant and offers additional protection of the pellets until it is degraded by microbial enzymes at the colon region. In vitro data indicates that inulin is a promising coating material to obtain timed and enzyme-triggered ibuprofen release. Pharmacokinetic study in New Zealand rabbit confirmed the in vitro data and revealed a delayed absorption of about 3 h but with higher AUC. This result suggests that inulin-shellac system shows potential materials to provide a microbial triggered drug in the colon compartment. The higher AUC of ibuprofen from double coated pellet dosage form may indicate that absorption of ibuprofen in colonic compartment is more extensive than in gastric.

Full text article

Generated from XML file

Authors

Heni Rachmawati
h_rachmawati@fa.itb.ac.id (Primary Contact)
Diky Mudhakir
Janti Kusuma
Heni Rachmawati, Diky Mudhakir, & Janti Kusuma. (2012). Combination of inulin-shellac as a unique coating formulation for design of colonic delivery dosage form of ibuprofen. International Journal of Research in Pharmaceutical Sciences, 3(1), 17–23. Retrieved from https://ijrps.com/home/article/view/3228

Article Details

No Related Submission Found